Quadintel offers a thorough analysis of the Blood Plasma Products Market, including assessments of business solutions, studies and advancements, applications, advantages, benefits, and breadth. This market research study on Blood Plasma Products Market provides a thorough analysis and improvement of the important business producers, opportunities, difficulties, and worldwide suppliers as well as a close investigation of risks and access restrictions. Additionally, it provides a competitive analysis of the most recent technological advancements, innovations, future market potential, industry share, sales, sales generation, funding analysis, and overall business environment.
Request To Download Sample of This Strategic Report: –https://www.quadintel.com/request-sample/india-blood-plasma-products-market/QI042
The market increased at a CAGR of 11.26% during the FY 2016 FY 2020 period and is expected to reach INR ~10.43 Bn by FY 2025.
Major players operating in the market include Bharat Serums and Vaccines Ltd. (BSV), Intas Pharmaceuticals Ltd., PlasmaGen BioSciences Private Ltd., Serum Institute of India Private Ltd., and Zydus Takeda Healthcare Private Ltd.
Plasma is a major component of the blood that plays an essential role in regulating bodily functions. It constitutes around 55% of the total volume of blood, and comprises more than 700 proteins and other substances. It is a major component used in the treatment of health problems such as haemophilia and autoimmune disorders. Improved diagnostic facilities and the prevalence of chronic diseases are major factors that have raised the demand for plasma-derived products. The blood plasma products market has been experiencing steady growth over the past few years. The immunoglobulin segment accounted for the major share of the market in 2020 and is projected to maintain its leading position during the forecast period.
Impact of COVID-19
The pandemic in India increased the need for convalescent measures, therapies, and cures for the ailing public. COVID-19 outbreak has pushed scientists to experiment with plasma therapy on infected people with the virus. This COVID-19 crisis highlighted the need for a massive supply of blood plasma for convalescent measures and treatments. Besides, India is heavily dependent on imported plasma products. These products fulfil 90% of the domestic demand, giving rise to a massive gap between demand and supply.
Market segment insights
In FY 2020, the immunoglobulin segment held the highest share (~46.78%) of the overall market. Immunoglobulin is used to treat various blood disorders such as primary and secondary immune deficiencies, and inflammatory and autoimmune diseases. Based on end users, the hospital segment dominated the market in FY 2020. Clinics and other end users segments are expected to expand at a growth rate of ~17.90% and ~24.77%, respectively, during the FY 2021 FY 2025 period.
Download Sample of This Strategic Report: –https://www.quadintel.com/request-sample/india-blood-plasma-products-market/QI042
Key growth drivers of the market
The demand for plasma derivative-based therapies has picked up in the wake of the pandemic, propelling market growth. According to a research study published in Blood Medicine Journal in 2016, FIX replacement therapy that comprises plasma-derived protein was found to be successful in reducing bleeding and disability in case of hemophilia B. According to the annual global survey conducted by the World Federation of hemophilia, around 50% of the world’s hemophilia population lives in India. Hemophilia is treated through factor replacement therapy, using clotting factor VIII for hemophilia A and clotting factor IX for hemophilia B Immunodeficiency can be caused by various chronic illnesses. Immunoglobulin, a crucial part of plasma protein, is used as first-line therapy to treat various immunologic, neurologic, and hematologic conditions. India has shown a remarkable improvement in patient care with Primary Immune Deficiencies (PIDs), and several centers of excellence in PIDs have emerged. Thus, an increase in the demand for immunoglobulin is fueling the growth of the market
Key deterrents to the growth of the market
Plasma derivative-based therapy is a cost-effective solution to develop human plasma products such as antibodies and proteins in the long run. It is an expensive procedure that involves the complicated process of collecting plasma, which requires a large workforce. The cost of plasmapheresis equipment, complex logistics, and donor compensation are very high. Apart from that, low availability of recovered plasma is another major challenge faced by plasma product manufacturers.
Companies covered
Bharat Serums and Vaccines Ltd. (BSV)
Bioviz Technologies Private Ltd.
Intas Pharmaceuticals Ltd.
PlasmaGen BioSciences Private Ltd.
Plasmatech Solutions Private Ltd.
Reliance Life Sciences Private Ltd.
Serum Institute of India Private Ltd.
Taj Pharma India Ltd.
Virchow Biotech Private Ltd.
Zydus Takeda Healthcare Private Ltd.
Download Sample of This Strategic Report –https://www.quadintel.com/request-sample/india-blood-plasma-products-market/QI042
Highlight the Following Key Factors:
- Business Description: a particular description of agency operations and enterprise departments.
- Company Strategy: The analyst’s precis of the company’s commercial enterprise strategy.
- SWOT Analysis: Detailed evaluation of the company’s strengths, weaknesses, opportunities, and threats.
- Company History: The development of predominant occasions associated to the company.
- Main merchandise and services: A listing of the company’s fundamental products, services, and brands.
- Main Competitors: A listing of the company’s fundamental competitors.
- Important places and subsidiaries: The company’s major places and subsidiaries’ listing and contact information.
- Detailed economic ratios of the previous 5 years: The trendy monetary ratios come from the annual economic statements issued by means of agencies with a record of 5 years.
Some of the Key Questions Answered in this Report:
- What will be the market size and the growth rate by the end of the forecast period?
- What are the key Player trends impacting the growth of the market?
- What are the potential growth opportunities and threats faced by the leading competitors in the market?
- What are the key outcomes of Porter’s five forces analysis and the SWOT analysis of the key players functioning in the global Market?
- This report gives all the information regarding industry Overview, analysis and revenue of this market.
- What are the market opportunities and threats faced by the vendors in the global Market?
Request Full Report–https://www.quadintel.com/request-sample/india-blood-plasma-products-market/QI042
About Quadintel:
We are the best market research reports provider in the industry. Quadintel believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Quadintel is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.
Get in Touch with Us:
Quadintel:
Email:sales@quadintel.com
Address: Office – 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
Tel: +1 888 212 3539 (US – TOLL FREE)
Website:https://www.quadintel.com/